How Trump Admin’s Psychedelic Drug Research Push Could Shake Up US Mental Healthcare System

0
75

The Trump administration’s recent push for psychedelic drugs in mental healthcare may significantly shake up the industry.

President Donald Trump issued an executive order in April aiming to “accelerate innovative research models and appropriate drug approvals to increase access to psychedelic drugs that could save lives and reverse the crisis of serious mental illness in America.” While some experts have touted the antidepressant effects of psychedelic-assisted mental healthcare treatments, others have raised concerns about potential ethical issues and gaps in psychedelic research. (RELATED: Trump Signs Executive Order Speeding Up Research On Using Psychedelics For Mental Health)

“Speeding [up] access is welcome,” CATO Institute Senior Fellow Jeff Singer told the Daily Caller News Foundation. “But psychedelic-assisted treatment is neither conventional drug therapy nor…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here